Evgeny N Imyanitov (Evgeny Imyanitov, E N Imyanitov)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 42

Top Topics

Positive Breast Cancer

Top Venues

International journal of molecular sciences

Exploration of targeted anti-tumor therapy

Medical sciences (Basel, Switzerland)

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Grigory A Yanus, Ekatherina Sh Kuligina, Evgeny N Imyanitov
Hereditary Renal Cancer Syndromes. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Grigoriy A Yanus, Evgeny N Suspitsin, Evgeny N Imyanitov
The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population. International journal of molecular sciences 25 (17) (2024)
Svetlana N Aleksakhina, Alexander O Ivantsov, Evgeny N Imyanitov
Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution. International journal of molecular sciences 25 (7) (2024)
Ekatherina Sh Kuligina, Aleksandr A Romanko, Tatjana Jankevic, Aleksandr S Martianov, Alexandr O Ivantsov, Tatyana N Sokolova, Dmitry Trofimov, Aniruddh Kashyap, Cezary Cybulski, Jan A Lubiński, Evgeny N Imyanitov
HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles. Breast cancer research and treatment (2024)
Grigory A Yanus, Ekatherina Sh Kuligina, Evgeny N Imyanitov
Hereditary Renal Cancer Syndromes. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Grigory A Yanus, Ekatherina Sh Kuligina, Evgeny N Imyanitov
Hereditary Renal Cancer Syndromes. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Svetlana N Aleksakhina, Alexander O Ivantsov, Evgeny N Imyanitov
Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution. International journal of molecular sciences 25 (7) (2024)
Grigory A Yanus, Ekatherina Sh Kuligina, Evgeny N Imyanitov
Hereditary Renal Cancer Syndromes. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Svetlana N Aleksakhina, Alexander O Ivantsov, Evgeny N Imyanitov
Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution. International journal of molecular sciences 25 (7) (2024)
Grigory A Yanus, Ekatherina Sh Kuligina, Evgeny N Imyanitov
Hereditary Renal Cancer Syndromes. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Fedor V Moiseyenko, Ekatherina Sh Kuligina, Ekaterina Elsakova, Evgeny N Imyanitov
Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors. Future oncology (London, England) (2024)
Evgeny N Imyanitov, Elena V Preobrazhenskaya, Sergey V Orlov
Current status of molecular diagnostics for lung cancer. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Aram A Musaelyan, Ekaterina M Anokhina, Alina I Turdubaeva, Natalia V Mitiushkina, Anastasia N Ershova, Anna D Shestakova, Aigul R Venina, Evgeny N Imyanitov, Sergey V Orlov
Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS -mutated metastatic intrahepatic cholangiocarcinoma: a case report. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Evgeny N Imyanitov, Elena V Preobrazhenskaya, Sergey V Orlov
Current status of molecular diagnostics for lung cancer. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Aram A Musaelyan, Ekaterina M Anokhina, Alina I Turdubaeva, Natalia V Mitiushkina, Anastasia N Ershova, Anna D Shestakova, Aigul R Venina, Evgeny N Imyanitov, Sergey V Orlov
Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS -mutated metastatic intrahepatic cholangiocarcinoma: a case report. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Aleksandr A Romanko, Rimma S Mulkidjan, Vladislav I Tiurin, Evgeniya S Saitova, Elena V Preobrazhenskaya, Elena A Krivosheyeva, Natalia V Mitiushkina, Anna D Shestakova, Evgeniya V Belogubova, Alexandr O Ivantsov, Aglaya G Iyevleva, Evgeny N Imyanitov
Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples. International journal of molecular sciences 24 (18) (2023)
Anna P Sokolenko, Fedor V Moiseyenko, Aglaya G Iyevleva, Alexandr O Ivantsov, Georgiy D Dolmatov, Ksenia V Shelekhova, Elizaveta V Gulo, Anastasya X Topal, Elizaveta V Artemieva, Nuriniso H Abduloeva, Nikita A Rysev, Daria A Barsova, Natalia V Levchenko, Nikita M Volkov, Vitaliy V Egorenkov, Vladimir M Moiseyenko, Evgeny N Imyanitov
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Anna P Sokolenko, Elvina Kh Bakaeva, Aigul R Venina, Ekatherina Sh Kuligina, Aleksandr A Romanko, Svetlana N Aleksakhina, Yana V Belysheva, Evgeniya V Belogubova, Ilya A Stepanov, Olga A Zaitseva, Olga S Yatsuk, Alexandr V Togo, Zaur M Khamgokov, Azinat O Kadyrova, Albert Sh Pirmagomedov, Marina B Bolieva, Alexandr A Epkhiev, Aslan K Tsutsaev, Madina D Chakhieva, Khalimat M Khabrieva, Idris M Khabriev, Mirza A Murachuev, Bella N Buttaeva, Liliya S Baboshkina, Fatima I Bayramkulova, Islam R Katchiev, Lina Kh Alieva, Grigory A Raskin, Sergey V Orlov, Zarema K Khachmamuk, Karine R Levonyan, Dariya M Gichko, Dmitriy V Kirtbaya, Alexey M Degtyariov, Luisa V Sultanova, Hedi S Musayeva, Alexey M Belyaev, Evgeny N Imyanitov
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus. Breast cancer research and treatment (2023)
Grigoriy A Yanus, Anna P Sokolenko, Evgeny N Imyanitov
Northern origin of the BRCA2 c.5286 T > G founder allele. Breast cancer research and treatment (2023)
Aleksandr S Martianov, Natalia V Mitiushkina, Anastasia N Ershova, Darya E Martynenko, Mikhail G Bubnov, Priscilla Amankwah, Grigoriy A Yanus, Svetlana N Aleksakhina, Vladislav I Tiurin, Aigul R Venina, Aleksandra A Anuskina, Yuliy A Gorgul, Anna D Shestakova, Mikhail A Maidin, Alexey M Belyaev, Liliya S Baboshkina, Aglaya G Iyevleva, Evgeny N Imyanitov
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas. International journal of molecular sciences 24 (5) (2023)
Alexey V Emshanov, Denis V Nesterov, Tatyana N Sokolova, Priscilla S Amankwah, Evgeny N Imyanitov
Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Rimma S Mulkidjan, Evgeniya S Saitova, Elena V Preobrazhenskaya, Karimat A Asadulaeva, Mikhail G Bubnov, Ekaterina A Otradnova, Darya M Terina, Sofia S Shulga, Darya E Martynenko, Maria V Semina, Evgeniya V Belogubova, Vladislav I Tiurin, Priscilla S Amankwah, Aleksandr S Martianov, Evgeny N Imyanitov
ALK , ROS1 , RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers. International journal of molecular sciences 24 (17) (2023)
Alexey V Emshanov, Denis V Nesterov, Tatyana N Sokolova, Priscilla S Amankwah, Evgeny N Imyanitov
Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Natalia V Mitiushkina, Vladislav I Tiurin, Aleksandra A Anuskina, Natalia A Bordovskaya, Anna D Shestakova, Aleksandr S Martianov, Mikhail G Bubnov, Anna S Shishkina, Maria V Semina, Aleksandr A Romanko, Ekatherina Sh Kuligina, Evgeny N Imyanitov
Molecular Analysis of Biliary Tract Cancers with the Custom 3' RACE-Based NGS Panel. Diagnostics (Basel, Switzerland) 13 (20) (2023)
Vladislav I Tiurin, Elena V Preobrazhenskaya, Natalia V Mitiushkina, Aleksandr A Romanko, Aleksandra A Anuskina, Rimma S Mulkidjan, Evgeniya S Saitova, Elena A Krivosheyeva, Elena D Kharitonova, Mikhail P Shevyakov, Ilya A Tryakin, Svetlana N Aleksakhina, Aigul R Venina, Tatiana N Sokolova, Aleksandr S Martianov, Anna D Shestakova, Alexandr O Ivantsov, Aglaya G Iyevleva, Evgeny N Imyanitov
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas. International journal of molecular sciences 24 (13) (2023)
Anna P Sokolenko, Fedor V Moiseyenko, Aglaya G Iyevleva, Alexandr O Ivantsov, Georgiy D Dolmatov, Ksenia V Shelekhova, Elizaveta V Gulo, Anastasya X Topal, Elizaveta V Artemieva, Nuriniso H Abduloeva, Nikita A Rysev, Daria A Barsova, Natalia V Levchenko, Nikita M Volkov, Vitaliy V Egorenkov, Vladimir M Moiseyenko, Evgeny N Imyanitov
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Aleksandr S Martianov, Natalia V Mitiushkina, Anastasia N Ershova, Darya E Martynenko, Mikhail G Bubnov, Priscilla Amankwah, Grigoriy A Yanus, Svetlana N Aleksakhina, Vladislav I Tiurin, Aigul R Venina, Aleksandra A Anuskina, Yuliy A Gorgul, Anna D Shestakova, Mikhail A Maidin, Alexey M Belyaev, Liliya S Baboshkina, Aglaya G Iyevleva, Evgeny N Imyanitov
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas. International journal of molecular sciences 24 (5) (2023)
Aleksandr S Martianov, Natalia V Mitiushkina, Anastasia N Ershova, Darya E Martynenko, Mikhail G Bubnov, Priscilla Amankwah, Grigoriy A Yanus, Svetlana N Aleksakhina, Vladislav I Tiurin, Aigul R Venina, Aleksandra A Anuskina, Yuliy A Gorgul, Anna D Shestakova, Mikhail A Maidin, Alexey M Belyaev, Liliya S Baboshkina, Aglaya G Iyevleva, Evgeny N Imyanitov
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas. International journal of molecular sciences 24 (5) (2023)
Anna P Sokolenko, Fedor V Moiseyenko, Aglaya G Iyevleva, Alexandr O Ivantsov, Georgiy D Dolmatov, Ksenia V Shelekhova, Elizaveta V Gulo, Anastasya X Topal, Elizaveta V Artemieva, Nuriniso H Abduloeva, Nikita A Rysev, Daria A Barsova, Natalia V Levchenko, Nikita M Volkov, Vitaliy V Egorenkov, Vladimir M Moiseyenko, Evgeny N Imyanitov
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Natalia V Mitiushkina, Grigoriy A Yanus, Ekatherina Sh Kuligina, Tatiana A Laidus, Alexandr A Romanko, Maksim M Kholmatov, Alexandr O Ivantsov, Svetlana N Aleksakhina, Evgeny N Imyanitov
Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1. International journal of molecular sciences 23 (9) (2022)
Fedor V Moiseyenko, Ekatherina Sh Kuligina, Albina S Zhabina, Sergey A Belukhin, Tatiana A Laidus, Aleksandr S Martianov, Kirill A Zagorodnev, Tatyana N Sokolova, Svetlana A Chuinyshena, Maksim M Kholmatov, Elizaveta V Artemieva, Ekaterina O Stepanova, Tatiana N Shuginova, Nikita M Volkov, Grigoriy A Yanus, Evgeny N Imyanitov
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer. International journal of clinical oncology 27 (5) (2022)
Evgeny N Imyanitov, Anna Sokolenko
Integrative Genomic Tests in Clinical Oncology. International journal of molecular sciences 23 (21) (2022)
Ludmila Papusha, Margarita Zaytseva, Agnesa Panferova, Alexander E Druy, Andge Valiakhmetova, Anton Artemov, Ekaterina Salnikova, Alexey Kislyakov, Evgeny N Imyanitov, Alexander Karachunskiy, Alexey A Maschan, Eugene I Hwang, Galina A Novichkova, Roger J Packer
Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib. Neuro-oncology 24 (6) (2022)
Valeriya I Ni, Alexandr O Ivantsov, Mariya A Kotkova, Sofia V Baskina, Elena V Ponomareva, Rashida V Orlova, Eldar E Topuzov, Kirill K Kryukov, Kseniya V Shelekhova, Svetlana N Aleksakhina, Anna P Sokolenko, Evgeny N Imyanitov
Small fraction of testicular cancer cases may be causatively related to CHEK2 inactivating germ-line mutations: evidence for somatic loss of the remaining CHEK2 allele in the tumor tissue. Familial cancer 20 (1) (2021)
Tatiana N Sokolova, Valeriy V Breder, Irina S Shumskaya, Evgeny N Suspitsin, Svetlana N Aleksakhina, Grigoriy A Yanus, Vladislav I Tiurin, Alexandr O Ivantsov, Barbara Vona, Grigoriy A Raskin, Sergey V Gamajunov, Evgeny N Imyanitov
Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine. Hereditary cancer in clinical practice 19 (1) (2021)
Evgeny N Imyanitov
Cytotoxic and targeted therapy for BRCA1/2-driven cancers. Hereditary cancer in clinical practice 19 (1) (2021)
M M Byakhova, L E Zavalishina, Yulia Yu Andreeva, Sergey A Tjulandin, Ilya Tsimafeyeu, Evgeny N Imyanitov, N A Savelov, I A Demidova, T V Kekeyeva, N M Mueva, G A Frank
[Epidemiology and diagnosis of mutations in the ALK gene in patients with non-small cell lung cancer in the Moscow region]. Arkhiv patologii 82 (3) (2020)
Artem Rafaelian, D E Alekseev, B V Martynov, A I Kholyavin, G V Papayan, M V Lytkin, D V Svistov, I S Zheleznyak, Evgeny N Imyanitov
[Stereotactic photodynamic therapy for recurrent glioblastoma. Case report and literature review]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 84 (5) (2020)
Elena V Preobrazhenskaya, Alla U Shleykina, Olga A Gorustovich, Alexandr S Martianov, Ilya V Bizin, Elena I Anisimova, Tatjana N Sokolova, Svetlana A Chuinyshena, Ekatherina Sh Kuligina, Alexandr V Togo, Alexey M Belyaev, Alexandr O Ivantsov, Anna P Sokolenko, Evgeny N Imyanitov
Frequency and molecular characteristics of PALB2-associated cancers in Russian patients. International journal of cancer 148 (1) (2020)
Anna P Sokolenko, Ilya V Bizin, Elena V Preobrazhenskaya, Tatiana V Gorodnova, Alexander O Ivantsov, Aglaya G Iyevleva, Elena L Savonevich, Khristina B Kotiv, Ekaterina Sh Kuligina, Evgeny N Imyanitov
Molecular profiles of BRCA1-associated ovarian cancer treated by platinum-based therapy: Analysis of primary, residual and relapsed tumors. International journal of cancer 146 (7) (2019)
Nikita M Volkov, Grigoriy A Yanus, Alexandr O Ivantsov, Fedor V Moiseenko, Olga G Matorina, Ilya V Bizin, Vladimir M Moiseyenko, Evgeny N Imyanitov
Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer. Investigational new drugs 38 (3) (2019)
Daria R Bulanova, Mikko Helenius, Anna P Sokolenko, Sergey G Kuznetsov, Evgeny N Imyanitov
Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers. International journal of cancer 144 (7) (2019)